News & Announcements
Item 1 of 3
Dr. Michael Seidman is Participating in a New Study to Test Treatment for Blast-induced Tinnitus.
Under the leadership of principal investigator Michael Seidman, MD, AdventHealth Research Institute is participating in the multi-site Clinical Trial of Etanercept (TNF-alpha Blocker) for Treatment of...
Item 2 of 3
AdventHealth’s Karen D. Corbin, PhD, RD, Contributed to New American Diabetes Association Consensus Statement on Liver Disease in Diabetes
Item 3 of 3
Dr. Kirk Erickson Joins the NavNeuro Podcast to Discuss the Connection Between Physical Activity and Brain Health
Recent Stories at AdventHealth Research Institute
-
-
Dr. Kirk Erickson Joins the NavNeuro Podcast to Discuss the Connection Between Physical Activity and Brain Health
-
Anita Fletcher, MD | Appointed by NKGen as National Principal Investigator for Phase 2a Troculeucel Trial
-
AdventHealth Research Contributed to New Method for Tracking Diet and Its Impacts on Human Health
-
Accelerating Orthopedic Innovation Through Research
-
Patricia Robinson, PhD | 50 Most Influential Clinical Executives - 2024 | Modern Healthcare
-
Richard E. Pratley, MD | Ozempic and Wegovy Slash Kidney Disease Risks in People With Diabetes
-
Anna Casu, MD | The Becker's Healthcare Podcast features Dr. Casu discussing her experience with T1 diabetes.
-
Richard E. Pratley, MD | The Becker's Healthcare Podcast features Dr. Pratley discussing the FLOW study